The average one-year price target for Octave Specialty Group (NYSE:AMBC) has been revised to $15.30 / share. This is an ...

Ambac Financial Group has officially rebranded as Octave Specialty Group, marking its transformation into a dedicated ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave, a leading neuroscience precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today ...

David Trick stated, "Adjusted EBITDA from continuing operations to stockholders was a loss of $3 million compared to a sub $2 ...

A behavioral healthcare startup has snagged $11 million from investors as it seeks to expand service in New York and San Francisco and sharpen its ability to work with insurers. “Payers are ...

The Catholic calendar has several ways to divide the Christmas season. The Church’s Western liturgical tradition sees Christmas as an octave, an eight-day celebration of the birth of Jesus Christ. The ...

Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis ...

Ambac Financial Group, Inc. (NYSE: AMBC) today announces it has rebranded to Octave Specialty Group, Inc. ("Octave"), marking ...

Ambac Financial Group, Inc. has rebranded as Octave Specialty Group, Inc. (Octave), a global specialty insurance firm, while ...